Skip to NavigationSkip to content


Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy

Published on: 04/01/18

Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein as its new President of Corporate and Product Strategy, where he will manage a range of responsibilities including product advancement and strategy, partnering and product protection, and corporate strategy.

Moderna appoint Novartis vet to scale-up manufacturing

Published on: 07/08/17

Moderna Therapeutics, a clinical stage biotechnology company, has appointed Juan Andres to the position of Senior Vice President of Late Stage Technical Development and Manufacturing. This long title will see Andres take charge of the company’s newly built manufacturing facility, that will become operational in 2018, and oversee further expansion into the production capabilities of the company.

Moderna Therapeutics instates MIT Treasurer to Board of Directors

Published on: 27/02/17

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. Israel Ruiz is currently the Executive Vice President and Treasurer at the Massachusetts Institute of Technology (MIT).

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches